Cardiorenal Syndrome: Diagnosis and Treatment
In the diagnosis of cardiorenal syndrome (CRS), the biological markers are widely used, they can be applied to identify the pathophysiological stages of CRS, to assess the amount of risk, prognosis and outcome, as well as to monitor the effectiveness of treatment. CRS therapy includes diuretics, vas...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2017-02-01
|
Series: | Počki |
Subjects: | |
Online Access: | http://kidneys.zaslavsky.com.ua/article/view/93777 |
id |
doaj-15ffc564f8dc4707925d681975e0ac07 |
---|---|
record_format |
Article |
spelling |
doaj-15ffc564f8dc4707925d681975e0ac072020-11-24T21:38:04ZengPublishing House ZaslavskyPočki 2307-12572307-12652017-02-016121410.22141/2307-1257.6.1.2017.9377793777Cardiorenal Syndrome: Diagnosis and TreatmentO.O. Melnyk0Specialized Medical Center «Optima-Pharm», Kyiv, UkraineIn the diagnosis of cardiorenal syndrome (CRS), the biological markers are widely used, they can be applied to identify the pathophysiological stages of CRS, to assess the amount of risk, prognosis and outcome, as well as to monitor the effectiveness of treatment. CRS therapy includes diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, nitrates and cardiac glycosides. One of the most effective methods of CRS treatment is the use of renal replacement therapy.http://kidneys.zaslavsky.com.ua/article/view/93777cardiorenal syndromebiomarkers of cardiorenal syndrome (cardiospecific, cardiorenal, glomerular, proximal, distal)treatment of cardiorenal syndrome (diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonist |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
O.O. Melnyk |
spellingShingle |
O.O. Melnyk Cardiorenal Syndrome: Diagnosis and Treatment Počki cardiorenal syndrome biomarkers of cardiorenal syndrome (cardiospecific, cardiorenal, glomerular, proximal, distal) treatment of cardiorenal syndrome (diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonist |
author_facet |
O.O. Melnyk |
author_sort |
O.O. Melnyk |
title |
Cardiorenal Syndrome: Diagnosis and Treatment |
title_short |
Cardiorenal Syndrome: Diagnosis and Treatment |
title_full |
Cardiorenal Syndrome: Diagnosis and Treatment |
title_fullStr |
Cardiorenal Syndrome: Diagnosis and Treatment |
title_full_unstemmed |
Cardiorenal Syndrome: Diagnosis and Treatment |
title_sort |
cardiorenal syndrome: diagnosis and treatment |
publisher |
Publishing House Zaslavsky |
series |
Počki |
issn |
2307-1257 2307-1265 |
publishDate |
2017-02-01 |
description |
In the diagnosis of cardiorenal syndrome (CRS), the biological markers are widely used, they can be applied to identify the pathophysiological stages of CRS, to assess the amount of risk, prognosis and outcome, as well as to monitor the effectiveness of treatment. CRS therapy includes diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, nitrates and cardiac glycosides. One of the most effective methods of CRS treatment is the use of renal replacement therapy. |
topic |
cardiorenal syndrome biomarkers of cardiorenal syndrome (cardiospecific, cardiorenal, glomerular, proximal, distal) treatment of cardiorenal syndrome (diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonist |
url |
http://kidneys.zaslavsky.com.ua/article/view/93777 |
work_keys_str_mv |
AT oomelnyk cardiorenalsyndromediagnosisandtreatment |
_version_ |
1725935607383851008 |